Making Health Care Work

LOWERING HEALTH CARE COSTS—We’re working to cut costs by cutting waste and focusing on prevention and care that get results.

LOWER COSTS, BETTER CARE

It’s a big year for health care. Many people have new options for coverage. And new protections are making existing health insurance work better. Take a look at our latest resources to help you make the most of the changes:

Health Insurance Tips - Top tips on getting the best deal on health insurance, and information about new consumer protections

So You Need Health Insurance, Now What? - The new young person's guide to health insurance

We’re excited to get the word out about these new options and consumer protections. But we also know there’s more to do to really make health care work across America. That’s why we’re advancing new initiatives to cut waste, improve care, and give consumers more control over their health.

The Health Insurance Marketplace

The state and federal health insurance marketplaces can help consumers and small businesses find a better deal on health coverage, with tools to compare plans, and information about new financial help. We’re working to make sure these marketplaces meet their potential to boost competition, reduce costs and improve quality.

Health Insurance Rate Watch

It’s time for health insurance companies to get serious about lowering the cost of care by cutting waste and focusing on preventive care that gets results – instead of raising deductibles and hiking premiums. We’re tracking insurers’ health insurance rate increase proposals, and working to strengthen protections for consumers and small businesses against excessive rates.

Fighting the High Cost of Rx Drugs

According to the Federal Trade Commission, Americans spend at least $3.5 billion more than they should have to on prescription drugs every year. That’s because drug companies use a practice called “pay for delay” to pay off their competitors to delay availability of the lower priced generic version of the drug. We’re working to put a stop to this practice.


Learn more about our priority campaign to end the pharmaceutical industry's scheme to delay cheaper drugs from entering the market:

Issue updates

News Release | U.S. PIRG | Health Care

Twenty Top Generic Drugs Delayed By Industry Payoffs

Americans with cancer, heart disease, epilepsy and other conditions have been forced to pay an average of 10 times more than necessary for at least 20 blockbuster drugs, according to a report released today by Community Catalyst and U.S. PIRG.

> Keep Reading
Report | U.S. PIRG | Health Care

Top Twenty Pay-For-Delay Drugs

Our research revealed 20 major drugs that were subject to an industry practice called “pay for delay,” in which brand name pharmaceutical companies pay off generic drug manufacturers to keep lower cost equivalents off the market, forcing consumers to pay higher brand-name drug prices.

> Keep Reading
News Release | U.S. PIRG | Health Care

Big Pharma's Pay-for-Delay Deals Take a Hit

Big Pharma's controversial "pay-for-delay" agreements took a hit today. In FTC v. Actavis, the U.S. Supreme Court ruled that the Federal Trade Commission (FTC) case against the payoff keeping generic AndroGel from the market can move ahead in the lower courts. The court chose not to declare all such payoffs unlawful, however, spurring consumer advocates to call on Congress to finish the job. 

> Keep Reading

Senate panel approves tighter oversight of compounding pharmacies but bill is under fire

Public health and consumer advocacy groups are attacking Senate legislation designed to tighten oversight of specialized pharmacies such as the one at the center of this past fall’s deadly meningitis outbreak, saying it does not adequately address health risks.

> Keep Reading
News Release | U.S. PIRG | Public Health, Health Care

New Report Documents a Decade of Safety Violations by Compounding Pharmacies

The contaminated drug that caused last fall's fungal meningitis outbreak and killed 55 people is just the tip of the iceberg of an industry-wide problem, according to a new U.S. PIRG report. The meningitis outbreak was simply the latest and deadliest in a long line of errors and risky practices by compounding pharmacies.

> Keep Reading

Pages

News Release | U.S. PIRG | Health Care

Big Pharma's Pay-for-Delay Deals Take a Hit

Big Pharma's controversial "pay-for-delay" agreements took a hit today. In FTC v. Actavis, the U.S. Supreme Court ruled that the Federal Trade Commission (FTC) case against the payoff keeping generic AndroGel from the market can move ahead in the lower courts. The court chose not to declare all such payoffs unlawful, however, spurring consumer advocates to call on Congress to finish the job. 

> Keep Reading

Senate panel approves tighter oversight of compounding pharmacies but bill is under fire

Public health and consumer advocacy groups are attacking Senate legislation designed to tighten oversight of specialized pharmacies such as the one at the center of this past fall’s deadly meningitis outbreak, saying it does not adequately address health risks.

> Keep Reading
News Release | U.S. PIRG | Public Health, Health Care

New Report Documents a Decade of Safety Violations by Compounding Pharmacies

The contaminated drug that caused last fall's fungal meningitis outbreak and killed 55 people is just the tip of the iceberg of an industry-wide problem, according to a new U.S. PIRG report. The meningitis outbreak was simply the latest and deadliest in a long line of errors and risky practices by compounding pharmacies.

> Keep Reading
Media Hit | Health Care

Los Angeles Times: Target, Rite Aid, Walgreens refill drugs without OK, patients say

Some consumers report Target, Rite Aid and Walgreens have refilled their prescription drugs without their approval, similar to allegations involving CVS.

> Keep Reading
News Release | U.S. PIRG | Health Care

Supreme Court Upholds Health Reform

Today’s decision is good news for consumers. Insurance companies can’t go back to the days of dropping your coverage once you become ill, or denying coverage to sick children. And beginning in 2014, the days of insurers being able to deny anyone coverage for “pre-existing conditions” will be history. 

> Keep Reading

Pages

Report | U.S. PIRG | Health Care

The Cost of Repeal for Young Adults

Before moving forward with the health care repeal, however, policy-makers must consider the real-life consequences that their policy choices would have on millions of young Americans. U.S. PIRG has examined official research, data, and projections from independent sources, to provide a detailed picture of repeal’s impact on young adults. The evidence reveals that young people would face significant costs if the Affordable Care Act is repealed.

> Keep Reading
Report | U.S. PIRG | Health Care

The Cost of Repeal

The evidence suggests that the costs of health care repeal are substantial and many of the asserted benefits of repeal do not stand up under scrutiny. But policy makers have additional options. They instead should work to implement the law properly in the states and take the steps to lower health care costs which the federal law fails to take.

> Keep Reading
Report | U.S. PIRG | Health Care

MAINE: The Cost of Repeal

The evidence suggests that the costs of health care repeal are substantial and many of the asserted benefits of repeal do not stand up under scrutiny. But Maine's policy makers have additional options. Maine instead should adapt the law's implementation to its needs and take the steps to lower health care costs which the federal law fails to take.

> Keep Reading
Report | U.S. PIRG Education Fund | Health Care

Delivering on the Promise

The recently passed federal health care reform law will make significant changes in how health insurance and health care work for consumers, businesses, and local and state governments, as well as how insurers and providers operate. But whether Americans experience improved care, lower costs and greater access depends largely on what happens next. 

> Keep Reading
Report | U.S. PIRG | Health Care

Uncovered

It's commonly assumed that young Americans are disengaged from the issue, that on the whole they are a healthy group who are unlikely to be affected by health problems or lack access to care. But the reality couldn't be more different. In fact, young people, including college students, are on the front lines of the health care crisis. They make up the largest age block of the uninsured, and face a uniquely challenging set of obstacles that often prevent them from getting coverage.

> Keep Reading

Pages

View AllRSS Feed

Support us

We’ve got a chance to clean up the health care industry, but with lobbyists lining the halls of state capitols across the country, we need your support.

PRIORITY ACTION

Tell your senator that patients can't afford to wait another day. We need to end "Pay for Delay" right now.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.
Optional Member Code